Ba/f3 Cell Line
Ba/f3 Cell Line - Related Videos
10:33
Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
0 Views •
Cited by 34 •
2019
Here, we present several simple methods for evaluating viability and death in 3D cancer cell spheroids, which mimic the physico-chemical gradients of in vivo tumors much better than the 2D culture. The spheroid model, therefore, allows evaluation of the cancer drug efficacy with improved translation to in vivo conditions.
09:04
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
0 Views •
Cited by 7 •
2016
We describe a simple cell-based bioassay for detecting, quantifying and monitoring the activity of members of the vascular endothelial growth factor family of ligands. The assay uses chimeric receptors expressed in a factor-dependent cell line to provide a semi-quantitative or quantitative assessment of receptor binding and cross-linking by the ligand.
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
0 Views •
2025
This protocol describes the in vivo reprogramming of mouse cancer cells into type 1 dendritic-like cells within the tumor microenvironment through enforced expression of the transcription factors PU.1, IRF8, and BATF3.
22:06
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
0 Views •
Cited by 8 •
2007
This protocol details the derivation of transplantable hematopoietic stem cells from mouse embryonic stem cells (ESC) and their subsequent injection into lethally irradiated recipient mice. Briefly, ESC are differentiated as embryoid bodies, which are then infected with retroviral HoxB4 and co-cultured with OP9 stromal cells and hematopoietic cytokines.
02:47
Human ES cells: Starting Culture from Frozen Cells
0 Views •
2006
Here we demonstrate how our lab begins a HuES human embryonic stem cell line culture from a frozen stock.
FAQs
IL-3 activates signaling through its associated receptor, providing the survival and proliferative signals that allow Ba/F3 cells to expand in culture. This cytokine-dependent response establishes the baseline state for experiments. Changes in growth after introducing an activated kinase or oncogenic fusion can therefore indicate that the introduced signal is substituting for normal IL-3-driven regulation.
Cytokine independence shows that an introduced kinase or oncogenic fusion can drive proliferation without the external IL-3 signal normally required by the cells. Comparing growth under IL-3-dependent and IL-3-independent conditions separates ordinary cytokine-supported expansion from growth associated with the introduced oncogenic activity, making the transformation phenotype measurable.
An activated kinase can test whether persistent kinase signaling is sufficient to alter the growth requirement of Ba/F3 cells. If proliferation occurs without IL-3 after the kinase is introduced, the result supports a functional connection between that kinase activity and the signaling processes controlling cell expansion. This links molecular activity to a visible cellular phenotype.
Ba/F3 cells allow researchers to compare growth responses associated with different kinase mutations or oncogenic variants under defined cytokine conditions. A mutation that changes inhibitor sensitivity can produce a different proliferation response than another variant, helping connect genotype with drug response. The system is consequently useful for examining how specific oncogenic alterations influence targeted treatment effects.
The assay begins with the IL-3-dependent growth state, followed by introduction of an activated kinase or oncogenic fusion. Researchers then assess proliferation under IL-3-dependent and cytokine-independent conditions and compare the resulting growth patterns. This design tests whether the introduced signal changes the cells' growth requirement and creates a measurable transformation phenotype.
Researchers use this model when they need to connect kinase activity with cellular proliferation and therapeutic response. By examining growth in cells carrying an activated kinase or oncogenic fusion, they can characterize whether a targeted inhibitor affects the associated signaling-driven phenotype. Comparisons with IL-3-supported growth also provide context for interpreting inhibitor effects in a cytokine-dependent background.